{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:24:16Z","timestamp":1793651056273,"version":"4.5.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["1401-2-412-58008"],"award-info":[{"award-number":["1401-2-412-58008"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s13346-025-01999-2","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T16:37:46Z","timestamp":1760978266000},"page":"2011-2033","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Localized co-delivery of in-situ hydrogel containing ibrutinib-PLGA-PEG-folate nanoparticle and octreotide microsphere to glioblastoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Bahar","family":"Morshedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3996-9612","authenticated-orcid":false,"given":"Mehdi","family":"Esfandyari-Manesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Ghahremani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Fatahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rassoul","family":"Dinarvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"issue":"4","key":"1999_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the Art and future directions. Cancer J Clin. 2020;70(4):299\u2013312.","journal-title":"Cancer J Clin"},{"issue":"3","key":"1999_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1124\/pr.117.014944","volume":"70","author":"A Shergalis","year":"2018","unstructured":"Shergalis A, Bankhead A, Luesakul U, Muangsin N, Neamati N. Current challenges and opportunities in treating glioblastoma. Pharmacol Rev. 2018;70(3):412\u201345.","journal-title":"Pharmacol Rev"},{"issue":"5","key":"1999_CR3","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1039\/D2BM01534J","volume":"11","author":"Y Wang","year":"2023","unstructured":"Wang Y, Bastiancich C, Newland B. Injectable local drug delivery systems for glioblastoma: a systematic review and meta-analysis of progress to date. Biomaterials Sci. 2023;11(5):1553\u201366.","journal-title":"Biomaterials Sci"},{"issue":"4","key":"1999_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4103\/2278-330X.175953","volume":"4","author":"S Roy","year":"2015","unstructured":"Roy S, Lahiri D, Maji T, Biswas J. Recurrent glioblastoma: where we stand. South Asian J Cancer. 2015;4(4):163\u201373.","journal-title":"South Asian J Cancer"},{"issue":"9","key":"1999_CR5","doi-asserted-by":"publisher","first-page":"2000027","DOI":"10.1002\/adtp.202000027","volume":"3","author":"CYX Chua","year":"2020","unstructured":"Chua CYX, Ho J, Demaria S, Ferrari M, Grattoni A. Emerging technologies for local cancer treatment. Adv Ther. 2020;3(9):2000027.","journal-title":"Adv Ther"},{"issue":"4","key":"1999_CR6","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.drudis.2016.02.014","volume":"21","author":"F Ramazani","year":"2016","unstructured":"Ramazani F, Van Nostrum CF, Storm G, Kiessling F, Lammers T, Hennink WE, et al. Locoregional cancer therapy using polymer-based drug depots. Drug Discovery Today. 2016;21(4):640\u20137.","journal-title":"Drug Discovery Today"},{"key":"1999_CR7","doi-asserted-by":"publisher","first-page":"113951","DOI":"10.1016\/j.addr.2021.113951","volume":"177","author":"C Bastiancich","year":"2021","unstructured":"Bastiancich C, Malfanti A, Pr\u00e9at V, Rahman R. Rationally designed drug delivery systems for the local treatment of resected glioblastoma. Adv Drug Deliv Rev. 2021;177:113951.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\u20132","key":"1999_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ijpharm.2012.06.025","volume":"436","author":"D Allhenn","year":"2012","unstructured":"Allhenn D, Boushehri MAS, Lamprecht A. Drug delivery strategies for the treatment of malignant gliomas. Int J Pharm. 2012;436(1\u20132):299\u2013310.","journal-title":"Int J Pharm"},{"issue":"1","key":"1999_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12957-016-0975-5","volume":"14","author":"LS Ashby","year":"2016","unstructured":"Ashby LS, Smith KA, Stea B. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant Temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review. World J Surg Oncol. 2016;14(1):225.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"1999_CR10","first-page":"e1479","volume":"10","author":"RW Chakroun","year":"2018","unstructured":"Chakroun RW, Zhang P, Lin R, Schiapparelli P, Quinones-Hinojosa A, Cui H. Nanotherapeutic systems for local treatment of brain tumors. Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol. 2018;10(1):e1479.","journal-title":"Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol"},{"issue":"3","key":"1999_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.14791\/btrt.2022.0017","volume":"10","author":"GD Cha","year":"2022","unstructured":"Cha GD, Jung S, Choi SH, Kim D-H. Local drug delivery strategies for glioblastoma treatment. Brain Tumor Res Treat. 2022;10(3):151.","journal-title":"Brain Tumor Res Treat"},{"issue":"8","key":"1999_CR12","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00701-012-1413-2","volume":"154","author":"P De Bonis","year":"2012","unstructured":"De Bonis P, Anile C, Pompucci A, Fiorentino A, Balducci M, Chiesa S, et al. Safety and efficacy of gliadel wafers for newly diagnosed and recurrent glioblastoma. Acta Neurochir (Wien). 2012;154(8):1371\u20138.","journal-title":"Acta Neurochir (Wien)"},{"issue":"11","key":"1999_CR13","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.drudis.2016.07.006","volume":"21","author":"M Norouzi","year":"2016","unstructured":"Norouzi M, Nazari B, Miller DW. Injectable hydrogel-based drug delivery systems for local cancer therapy. Drug Discov Today. 2016;21(11):1835\u201349.","journal-title":"Drug Discov Today"},{"issue":"6","key":"1999_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/mabi.200900402","volume":"10","author":"MK Nguyen","year":"2010","unstructured":"Nguyen MK, Lee DS. Injectable biodegradable hydrogels. Macromol Biosci. 2010;10(6):563\u201379.","journal-title":"Macromol Biosci"},{"issue":"6","key":"1999_CR15","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1039\/C1CS15203C","volume":"41","author":"Y Li","year":"2012","unstructured":"Li Y, Rodrigues J, Tom\u00e1s H. Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications. Chem Soc Rev. 2012;41(6):2193\u2013221.","journal-title":"Chem Soc Rev"},{"key":"1999_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s42242-020-00084-6","volume":"3","author":"J Thakor","year":"2020","unstructured":"Thakor J, Ahadian S, Niakan A, Banton E, Nasrollahi F, Hasani-Sadrabadi MM, et al. Engineered hydrogels for brain tumor culture and therapy. Bio-design Manuf. 2020;3:203\u201326.","journal-title":"Bio-design Manuf"},{"key":"1999_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jconrel.2016.09.034","volume":"243","author":"C Bastiancich","year":"2016","unstructured":"Bastiancich C, Danhier P, Pr\u00e9at V, Danhier F. Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma. J Controlled Release. 2016;243:29\u201342.","journal-title":"J Controlled Release"},{"key":"1999_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.biomaterials.2015.08.045","volume":"73","author":"K Yue","year":"2015","unstructured":"Yue K, Trujillo-de Santiago G, Alvarez MM, Tamayol A, Annabi N, Khademhosseini A. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials. 2015;73:254\u201371.","journal-title":"Biomaterials"},{"issue":"11","key":"1999_CR19","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3390\/polym10111290","volume":"10","author":"M Sun","year":"2018","unstructured":"Sun M, Sun X, Wang Z, Guo S, Yu G, Yang H. Synthesis and properties of gelatin methacryloyl (GelMA) hydrogels and their recent applications in load-bearing tissue. Polymers. 2018;10(11):1290.","journal-title":"Polymers"},{"issue":"11","key":"1999_CR20","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.3109\/10428194.2013.777837","volume":"54","author":"JA Burger","year":"2013","unstructured":"Burger JA, Buggy JJ. Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765). Leuk Lymphoma. 2013;54(11):2385\u201391.","journal-title":"Leuk Lymphoma"},{"key":"1999_CR21","doi-asserted-by":"crossref","unstructured":"Charalambous A, Schwarzbich M-A, Witzens-Harig M. Ibrutinib. Small Molecules in Hematology. 2018:133\u2009\u2013\u200968.","DOI":"10.1007\/978-3-319-91439-8_7"},{"issue":"43","key":"1999_CR22","doi-asserted-by":"publisher","first-page":"69961","DOI":"10.18632\/oncotarget.11572","volume":"7","author":"L Wei","year":"2016","unstructured":"Wei L, Su YK, Lin CM, Chao TY, Huang SP, Huynh TT, et al. Preclinical investigation of ibrutinib, a bruton\u2019s kinase tyrosine (Btk) inhibitor, in suppressing glioma tumorigenesis and stem cell phenotypes. Oncotarget. 2016;7(43):69961\u201375.","journal-title":"Oncotarget"},{"key":"1999_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fnmol.2019.00002","volume":"12","author":"L Sala","year":"2019","unstructured":"Sala L, Cirillo G, Riva G, Romano G, Giussani C, Cialdella A, et al. Specific expression of a new Bruton tyrosine kinase isoform (p65BTK) in the glioblastoma gemistocytic histotype. Front Mol Neurosci. 2019;12:2.","journal-title":"Front Mol Neurosci"},{"key":"1999_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-017-0549-6","volume":"36","author":"J Wang","year":"2017","unstructured":"Wang J, Liu X, Hong Y, Wang S, Chen P, Gu A, et al. Ibrutinib, a bruton\u2019s tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma. J Experimental Clin Cancer Res. 2017;36:1\u201313.","journal-title":"J Experimental Clin Cancer Res"},{"key":"1999_CR25","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10456-018-9621-x","volume":"21","author":"DA Guerra","year":"2018","unstructured":"Guerra DA, Paiva AE, Sena IF, Azevedo PO, Silva WN, Mintz A, et al. Targeting glioblastoma-derived pericytes improves chemotherapeutic outcome. Angiogenesis. 2018;21:667\u201375.","journal-title":"Angiogenesis"},{"issue":"1","key":"1999_CR26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/21691401.2022.2118758","volume":"50","author":"A Patra","year":"2022","unstructured":"Patra A, Satpathy S, Naik PK, Kazi M, Hussain MD. Folate receptor-targeted PLGA-PEG nanoparticles for enhancing the activity of genistein in ovarian cancer. Artif Cells Nanomed Biotechnol. 2022;50(1):228\u201339.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"32","key":"1999_CR27","doi-asserted-by":"publisher","first-page":"25518","DOI":"10.1039\/C5RA00018A","volume":"5","author":"JJ Pillai","year":"2015","unstructured":"Pillai JJ, Thulasidasan AKT, Anto RJ, Devika NC, Ashwanikumar N, Kumar GV. Curcumin entrapped folic acid conjugated PLGA\u2013PEG nanoparticles exhibit enhanced anticancer activity by site specific delivery. RSC Adv. 2015;5(32):25518\u201324.","journal-title":"RSC Adv"},{"issue":"1","key":"1999_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1515\/rams-2021-0009","volume":"60","author":"E Ortiz-Islas","year":"2021","unstructured":"Ortiz-Islas E, Sosa-Arr\u00f3niz A, Manr\u00edquez-Ram\u00edrez ME, Rodr\u00edguez-P\u00e9rez CE, Tzompantzi F, Padilla JM. Mesoporous silica nanoparticles functionalized with folic acid for targeted release Cis-Pt to glioblastoma cells. Reviews Adv Mater Sci. 2021;60(1):25\u201337.","journal-title":"Reviews Adv Mater Sci"},{"key":"1999_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11060-018-2747-2","volume":"137","author":"GD Arnone","year":"2018","unstructured":"Arnone GD, Bhimani AD, Aguilar T, Mehta AI. Localized targeted antiangiogenic drug delivery for glioblastoma. J Neurooncol. 2018;137:223\u201331.","journal-title":"J Neurooncol"},{"issue":"12","key":"1999_CR30","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.3390\/ijms21124490","volume":"21","author":"G Nery de Albuquerque Rego","year":"2020","unstructured":"Nery de Albuquerque Rego G, da Hora Alves A, Penteado Nucci M, Bustamante Mamani J, Anselmo de Oliveira F, Gamarra LF. Antiangiogenic targets for glioblastoma therapy from a Pre-Clinical Approach, using nanoformulations. Int J Mol Sci. 2020;21(12):4490.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1999_CR31","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrn2175","volume":"8","author":"RK Jain","year":"2007","unstructured":"Jain RK, Di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. Angiogenesis in brain tumours. Nat Rev Neurosci. 2007;8(8):610\u201322.","journal-title":"Nat Rev Neurosci"},{"key":"1999_CR32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.colsurfb.2017.05.038","volume":"156","author":"T Chen","year":"2017","unstructured":"Chen T, Song X, Gong T, Fu Y, Yang L, Zhang Z, et al. nRGD modified Lycobetaine and octreotide combination delivery system to overcome multiple barriers and enhance anti-glioma efficacy. Colloids Surf B Biointerfaces. 2017;156:330\u20139.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"6","key":"1999_CR33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/01.cad.0000210335.95828.ed","volume":"17","author":"LK Kvols","year":"2006","unstructured":"Kvols LK, Woltering EA. Role of somatostatin analogs in the clinical management of non-neuroendocrine solid tumors. Anticancer Drugs. 2006;17(6):601\u20138.","journal-title":"Anticancer Drugs"},{"key":"1999_CR34","first-page":"1","volume":"just\u2013accepted","author":"B Morshedi","year":"2025","unstructured":"Morshedi B, Esfandyari-Manesh M, Atyabi F, Ghahremani MH, Dinarvand R. Local delivery of ibrutinib by folate receptor-mediated targeting PLGA-PEG nanoparticles to glioblastoma multiform: in vitro and in vivo studies. J Drug Target. 2025;just\u2013accepted:1\u201316.","journal-title":"J Drug Target"},{"key":"1999_CR35","doi-asserted-by":"crossref","unstructured":"Fasehee H, Dinarvand R, Ghavamzadeh A, Esfandyari-Manesh M, Moradian H, Faghihi S et al. Delivery of Disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations. J Nanobiotechnol. 2016;14(1).","DOI":"10.1186\/s12951-016-0183-z"},{"issue":"11","key":"1999_CR36","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1021\/acs.molpharmaceut.0c00619","volume":"17","author":"A Beig","year":"2020","unstructured":"Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, et al. Physical-Chemical characterization of octreotide encapsulated in commercial Glucose-Star PLGA microspheres. Mol Pharm. 2020;17(11):4141\u201351.","journal-title":"Mol Pharm"},{"issue":"21","key":"1999_CR37","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1016\/j.biomaterials.2010.03.064","volume":"31","author":"JW Nichol","year":"2010","unstructured":"Nichol JW, Koshy ST, Bae H, Hwang CM, Yamanlar S, Khademhosseini A. Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials. 2010;31(21):5536\u201344.","journal-title":"Biomaterials"},{"key":"1999_CR38","doi-asserted-by":"crossref","unstructured":"Sun M, Sun X, Wang Z, Guo S, Yu G, Yang H. Synthesis and properties of gelatin methacryloyl (GelMA) hydrogels and their recent applications in Load-Bearing tissue. Polym (Basel). 2018;10(11).","DOI":"10.3390\/polym10111290"},{"key":"1999_CR39","doi-asserted-by":"publisher","first-page":"213254","DOI":"10.1016\/j.bioadv.2022.213254","volume":"145","author":"T Ghahri","year":"2023","unstructured":"Ghahri T, Salehi Z, Aghajanpour S, Eslaminejad MB, Kalantari N, Akrami M, et al. Development of osteon-like scaffold-cell construct by quadruple coaxial extrusion-based 3D Bioprinting of nanocomposite hydrogel. Biomater Adv. 2023;145:213254.","journal-title":"Biomater Adv"},{"key":"1999_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejphar.2019.04.007","volume":"854","author":"B Mirani","year":"2019","unstructured":"Mirani B, Pagan E, Shojaei S, Duchscherer J, Toyota BD, Ghavami S, et al. A 3D bioprinted hydrogel mesh loaded with all-trans retinoic acid for treatment of glioblastoma. Eur J Pharmacol. 2019;854:201\u201312.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1999_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ajco.12419","volume":"12","author":"JQ Huang","year":"2016","unstructured":"Huang JQ, Liang HL, Zhang XC, Xie Z, Jin TE. Synergistic antitumor activity of pro-apoptotic agent PAC-1 with cisplatinum by the activation of CASP3 in pulmonary adenocarcinoma cell line H1299. Asia Pac J Clin Oncol. 2016;12(1):41\u201351.","journal-title":"Asia Pac J Clin Oncol"},{"key":"1999_CR42","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.2147\/DDDT.S186028","volume":"12","author":"J Shen","year":"2018","unstructured":"Shen J, Zhang Y, Shen H, Pan H, Xu L, Yuan L, et al. The synergistic effect of 2,3,5,4\u2019-Tetrahydroxystilbene-2-O-\u03b2-d-glucoside combined with adriamycin on MCF-7 breast cancer cells. Drug Des Devel Ther. 2018;12:4083\u201394.","journal-title":"Drug Des Devel Ther"},{"key":"1999_CR43","doi-asserted-by":"crossref","unstructured":"Vijayalakshmi S, Subramanian S, Malathi S. Chou-Talalay analysis: exploring synergistic Pharmacological effects of 5-Fluorouracil and Curcumin for dose optimization. Int J Pharm Invest. 2024;14(3).","DOI":"10.5530\/ijpi.14.3.94"},{"key":"1999_CR44","doi-asserted-by":"crossref","unstructured":"Yang J, Wang Z, Ma C, Tang H, Hao H, Li M et al. Advances in hydrogels of drug delivery systems for the local treatment of brain tumors. Gels. 2024;10(6).","DOI":"10.3390\/gels10060404"},{"issue":"1","key":"1999_CR45","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ijpharm.2018.07.033","volume":"548","author":"M Zhao","year":"2018","unstructured":"Zhao M, Danhier F, Bastiancich C, Joudiou N, Ganipineni LP, Tsakiris N, et al. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival. Int J Pharm. 2018;548(1):522\u20139.","journal-title":"Int J Pharm"},{"key":"1999_CR46","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jconrel.2019.07.015","volume":"309","author":"M Zhao","year":"2019","unstructured":"Zhao M, Bozzato E, Joudiou N, Ghiassinejad S, Danhier F, Gallez B, et al. Codelivery of Paclitaxel and Temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection. J Controlled Release. 2019;309:72\u201381.","journal-title":"J Controlled Release"},{"key":"1999_CR47","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.wneu.2017.04.053","volume":"103","author":"M Rapp","year":"2017","unstructured":"Rapp M, Baernreuther J, Turowski B, Steiger H-J, Sabel M, Kamp MA. Recurrence pattern analysis of primary glioblastoma. World Neurosurg. 2017;103:733\u201340.","journal-title":"World Neurosurg"},{"key":"1999_CR48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jconrel.2017.08.019","volume":"264","author":"C Bastiancich","year":"2017","unstructured":"Bastiancich C, Bianco J, Vanvarenberg K, Ucakar B, Joudiou N, Gallez B, et al. Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection. J Control Release. 2017;264:45\u201354.","journal-title":"J Control Release"},{"issue":"19","key":"1999_CR49","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1039\/D0BM00338G","volume":"8","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Shen J, Zhang L, Wang L, Xu H, Han Y, et al. Injectable postoperative enzyme-responsive hydrogels for reversing Temozolomide resistance and reducing local recurrence after glioma operation. Biomater Sci. 2020;8(19):5306\u201316.","journal-title":"Biomater Sci"},{"key":"1999_CR50","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jconrel.2016.01.054","volume":"225","author":"C Bastiancich","year":"2016","unstructured":"Bastiancich C, Vanvarenberg K, Ucakar B, Pitorre M, Bastiat G, Lagarce F, et al. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma. J Control Release. 2016;225:283\u201393.","journal-title":"J Control Release"},{"key":"1999_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-019-1438-4","volume":"20","author":"T Wang","year":"2019","unstructured":"Wang T, Zhang C, Zhong W, Yang X, Wang A, Liang R. Modification of three-phase drug release mode of octreotide PLGA microspheres by microsphere-gel composite system. AAPS PharmSciTech. 2019;20:1\u201314.","journal-title":"AAPS PharmSciTech"},{"key":"1999_CR52","doi-asserted-by":"publisher","first-page":"101627","DOI":"10.1016\/j.jddst.2020.101627","volume":"57","author":"O Sayiner","year":"2020","unstructured":"Sayiner O, Arisoy S, Comoglu T, Ozbay FG, Esendagli G. Development and in vitro evaluation of temozolomide-loaded PLGA nanoparticles in a thermoreversible hydrogel system for local administration in glioblastoma multiforme. J Drug Deliv Sci Technol. 2020;57:101627.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"1999_CR53","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/ma11050779","volume":"11","author":"L Nam","year":"2018","unstructured":"Nam L, Coll C, Erthal L, De la Torre C, Serrano D, Mart\u00ednez-M\u00e1\u00f1ez R, et al. Drug delivery nanosystems for the localized treatment of glioblastoma multiforme. Materials. 2018;11(5):779.","journal-title":"Materials"},{"issue":"6","key":"1999_CR54","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/jphp.12550","volume":"68","author":"F Shakeel","year":"2016","unstructured":"Shakeel F, Iqbal M, Ezzeldin E. Bioavailability enhancement and Pharmacokinetic profile of an anticancer drug ibrutinib by self-nanoemulsifying drug delivery system. J Pharm Pharmacol. 2016;68(6):772\u201380.","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"1999_CR55","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1038\/s41598-019-40660-0","volume":"9","author":"M Verheijen","year":"2019","unstructured":"Verheijen M, Lienhard M, Schrooders Y, Clayton O, Nudischer R, Boerno S, et al. DMSO induces drastic changes in human cellular processes and epigenetic landscape in vitro. Sci Rep. 2019;9(1):4641.","journal-title":"Sci Rep"},{"key":"1999_CR56","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.addr.2017.06.011","volume":"119","author":"V Askoxylakis","year":"2017","unstructured":"Askoxylakis V, Arvanitis CD, Wong CS, Ferraro GB, Jain RK. Emerging strategies for delivering antiangiogenic therapies to primary and metastatic brain tumors. Adv Drug Deliv Rev. 2017;119:159\u201374.","journal-title":"Adv Drug Deliv Rev"},{"key":"1999_CR57","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s12035-020-01892-8","volume":"57","author":"BK Ahir","year":"2020","unstructured":"Ahir BK, Engelhard HH, Lakka SS. Tumor development and angiogenesis in adult brain tumor: glioblastoma. Mol Neurobiol. 2020;57:2461\u201378.","journal-title":"Mol Neurobiol"},{"issue":"1\u20132","key":"1999_CR58","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.mce.2008.02.002","volume":"286","author":"S Pyronnet","year":"2008","unstructured":"Pyronnet S, Bousquet C, Najib S, Azar R, Laklai H, Susini C. Antitumor effects of somatostatin. Mol Cell Endocrinol. 2008;286(1\u20132):230\u20137.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"1999_CR59","first-page":"625","volume":"5","author":"LMS Philo","year":"2013","unstructured":"Philo LMS, Shah S, Badarinath A, Gopinath C. Formulation and evaluation of octreotide acetate loaded PLGA microspheres. Int J Pharm Pharm Sci. 2013;5(3):625\u201362.","journal-title":"Int J Pharm Pharm Sci"},{"key":"1999_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02980037","volume":"27","author":"Y Yeo","year":"2004","unstructured":"Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res. 2004;27:1\u201312.","journal-title":"Arch Pharm Res"},{"issue":"1\u20132","key":"1999_CR61","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","volume":"415","author":"S Fredenberg","year":"2011","unstructured":"Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The mechanisms of drug release in Poly (lactic-co-glycolic acid)-based drug delivery systems\u2014A review. Int J Pharm. 2011;415(1\u20132):34\u201352.","journal-title":"Int J Pharm"},{"key":"1999_CR62","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jconrel.2018.07.044","volume":"286","author":"I Mylonaki","year":"2018","unstructured":"Mylonaki I, All\u00e9mann E, Delie F, Jordan O. Imaging the porous structure in the core of degrading PLGA microparticles: the effect of molecular weight. J Controlled Release. 2018;286:231\u20139.","journal-title":"J Controlled Release"},{"key":"1999_CR63","doi-asserted-by":"publisher","first-page":"104990","DOI":"10.1016\/j.ejps.2019.104990","volume":"138","author":"T Wang","year":"2019","unstructured":"Wang T, Xue P, Wang A, Yin M, Han J, Tang S, et al. Pore change during degradation of octreotide acetate-loaded PLGA microspheres: the effect of polymer blends. Eur J Pharm Sci. 2019;138:104990.","journal-title":"Eur J Pharm Sci"},{"key":"1999_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matdes.2018.08.062","volume":"160","author":"D Mao","year":"2018","unstructured":"Mao D, Li Q, Li D, Tan Y, Che Q. 3D porous Poly (\u03b5-caprolactone)\/58S bioactive glass\u2013sodium alginate\/gelatin hybrid scaffolds prepared by a modified melt molding method for bone tissue engineering. Mater Design. 2018;160:1\u20138.","journal-title":"Mater Design"},{"issue":"10","key":"1999_CR65","doi-asserted-by":"publisher","first-page":"e0163902","DOI":"10.1371\/journal.pone.0163902","volume":"11","author":"HJ Yoon","year":"2016","unstructured":"Yoon HJ, Shin SR, Cha JM, Lee SH, Kim JH, Do JT, et al. Cold water fish gelatin methacryloyl hydrogel for tissue engineering application. PLoS ONE. 2016;11(10):e0163902.","journal-title":"PLoS ONE"},{"key":"1999_CR66","doi-asserted-by":"crossref","unstructured":"Kwon S, Lee SS, Sivashanmugam A, Kwon J, Kim SHL, Noh MY et al. Bioglass-Incorporated methacrylated gelatin cryogel for regeneration of bone defects. Polym (Basel). 2018;10(8).","DOI":"10.3390\/polym10080914"},{"issue":"8","key":"1999_CR67","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1177\/0885328218823329","volume":"33","author":"S Krishnamoorthy","year":"2019","unstructured":"Krishnamoorthy S, Zhang Z, Xu C. Biofabrication of three-dimensional cellular structures based on gelatin methacrylate\u2013alginate interpenetrating network hydrogel. J Biomater Appl. 2019;33(8):1105\u201317.","journal-title":"J Biomater Appl"},{"issue":"27","key":"1999_CR68","doi-asserted-by":"publisher","first-page":"17433","DOI":"10.1021\/acsomega.1c01806","volume":"6","author":"C Ma","year":"2021","unstructured":"Ma C, Choi JB, Jang YS, Kim SY, Bae TS, Kim YK, et al. Mammalian and fish gelatin Methacryloyl-Alginate interpenetrating polymer network hydrogels for tissue engineering. ACS Omega. 2021;6(27):17433\u201341.","journal-title":"ACS Omega"},{"issue":"44","key":"1999_CR69","doi-asserted-by":"publisher","first-page":"27449","DOI":"10.1039\/C7RA03214E","volume":"7","author":"Q Dou","year":"2017","unstructured":"Dou Q, Low ZWK, Zhang K, Loh XJ. A new light triggered approach to develop a micro porous tough hydrogel. RSC Adv. 2017;7(44):27449\u201353.","journal-title":"RSC Adv"},{"key":"1999_CR70","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jmbbm.2012.01.022","volume":"10","author":"B Rashid","year":"2012","unstructured":"Rashid B, Destrade M, Gilchrist MD. Mechanical characterization of brain tissue in compression at dynamic strain rates. J Mech Behav Biomed Mater. 2012;10:23\u201338.","journal-title":"J Mech Behav Biomed Mater"},{"issue":"4","key":"1999_CR71","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/ijc.1223","volume":"92","author":"R Mentlein","year":"2001","unstructured":"Mentlein R, Eichler O, Forstreuter F, Held-Feindt J. Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells. Int J Cancer. 2001;92(4):545\u201350.","journal-title":"Int J Cancer"},{"key":"1999_CR72","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0026-0495(96)90080-3","volume":"45","author":"R Danesi","year":"1996","unstructured":"Danesi R, Del Tacca M. The effects of the somatostatin analog octreotide on angiogenesis in vitro. Metabolism. 1996;45:49\u201350.","journal-title":"Metabolism"},{"key":"1999_CR73","doi-asserted-by":"crossref","unstructured":"Shi Y, Guryanova OA, Zhou W, Liu C, Huang Z, Fang X et al. Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance. Sci Transl Med. 2018;10(443).","DOI":"10.1126\/scitranslmed.aah6816"},{"issue":"3","key":"1999_CR74","first-page":"105","volume":"22","author":"D Giakoumettis","year":"2018","unstructured":"Giakoumettis D, Kritis A, Foroglou N. C6 cell line: the gold standard in glioma research. Hippokratia. 2018;22(3):105\u201312.","journal-title":"Hippokratia"},{"issue":"3","key":"1999_CR75","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3171\/2016.8.JNS16995","volume":"127","author":"T Graillon","year":"2016","unstructured":"Graillon T, Romano D, Defilles C, Saveanu A, Mohamed A, Figarella-Branger D, et al. Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review. J Neurosurg. 2016;127(3):660\u20139.","journal-title":"J Neurosurg"},{"issue":"15","key":"1999_CR76","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1039\/C9NJ05366B","volume":"44","author":"H Han","year":"2020","unstructured":"Han H, Zhang Y, Jin S, Chen P, Liu S, Xie Z, et al. Paclitaxel-loaded dextran nanoparticles decorated with RVG29 peptide for targeted chemotherapy of glioma: an in vivo study. New J Chem. 2020;44(15):5692\u2013701.","journal-title":"New J Chem"},{"key":"1999_CR77","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41571-025-01020-2","volume":"22","author":"T Kisby","year":"2025","unstructured":"Kisby T, Borst GR, Coope DJ, et al. Targeting the glioblastoma resection margin with locoregional nanotechnologies. Nat Rev Clin Oncol. 2025;22:517\u201337.","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01999-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01999-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01999-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:03:27Z","timestamp":1779113007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01999-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1999"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01999-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7357228\/v1","asserted-by":"object"}]},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent tO participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}